DOD funds $8 million grant for PEMGARDA Long COVID Clinical Trial!

PROBE-PASC, a new clinical trial will test Pemgarda and hydroxychloroquine alone and in combination. The new trial was announced at the ISLC-PAIS conference a two weeks ago by Michael Peluso, an infectious disease researcher at the University of California, San Francisco. For more information, see the below article.

Department of Defense funds $8 million grant for Long COVID trials - The Sick Times

https://thesicktimes.org/2026/09/01/department-of-defense-funds-8-million-grant-for-long-covid-trials/